tailieunhanh - Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomes

Determining the driving factors and molecular flow-through that define the switch from favorable to aggressive high-risk disease is critical to the betterment of neuroblastoma cure. In this study, we examined the cytogenetic and tumorigenic physiognomies of distinct population of metastatic site- derived aggressive cells (MSDACs) from high-risk tumors, and showed the influence of acquired genetic rearrangements on poor patient outcomes. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN